| |
| |
|
| Insider
Information: |
Reardon Andrew |
| Relationship: |
CHIEF LEGAL OFFICER & |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
22,205 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,551,907 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
22,205 |
|
|
| Total
Value |
$1,551,907 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
CHIEF LEGAL OFFICER & |
2024-02-27 |
22,205 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
CHIEF LEGAL OFFICER & |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,208 |
22,205 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
CHIEF LEGAL OFFICER & |
• – – |
2024-02-15 |
4 |
D |
$74.65 |
$44,267 |
D/D |
(593) |
14,997 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
CHIEF LEGAL OFFICER & |
• – – |
2023-12-29 |
4 |
A |
$60.71 |
$10,867 |
D/D |
179 |
15,590 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
CHIEF LEGAL OFFICER & |
• – – |
2023-08-10 |
4 |
D |
$68.73 |
$61,651 |
D/D |
(897) |
15,411 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
See Remarks |
• – – |
2023-03-24 |
4 |
S |
$69.92 |
$20,977 |
D/D |
(300) |
16,308 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
See Remarks |
• – – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,668 |
16,608 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
See Remarks |
• – – |
2022-11-30 |
4 |
D |
$72.90 |
$78,222 |
D/D |
(1,073) |
10,940 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
See RemarksOfficer |
• – – |
2022-11-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,013 |
|
% |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
